| [1] |
Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet, 2010, 376(9741):631-644.
|
| [2] |
Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol, 2009, 33(3):130-137.
|
| [3] |
Wallis AB, Saftlas AF, Hsia J, et al. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens, 2008, 21(5):521-526.
|
| [4] |
Salas SP. What causes pre-eclampsia？. Best Pract Res Clin Obstet Gynaecol, 1999, 13(1):41-57.
|
| [5] |
Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet, 2001, 357(9251):209-215.
|
| [6] |
Dildy GA, Belfort MA, Smulian JC. Pre-eclampsia recurrence and prevention. Semin Perinatol, 2007, 31(3):135-141.
|
| [7] |
Leslie K, Thilaganathan B, Papageorghiou A. Early prediction and prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol, 2011, 25(3):343-354.
|
| [8] |
Conde-Agudelo A, Vilar J, Lindheimer M. World Health Organization systematic review of screening tests for pre-eclampsia. Obstet Gynecol, 2004, 104(6):1367-1391.
|
| [9] |
Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta, 2006, 27(9-10):939-958.
|
| [10] |
Nicolaides KH, Bindra R, Turan OM, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol, 2006, 27(1):13-17.
|
| [11] |
Ong CY, Liao AW, Spencer K, et al. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG, 2000, 107(10):1265-1270.
|
| [12] |
GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet, 2005, 77(1):127-131.
|
| [13] |
Ostendorf T, De Vriese AS, Floege J. Renal side effects of anti-VEGF theraphy in man: a new test system. Nephrol Dial transplant, 2007, 22(10):2778-2780.
|
| [14] |
Zimmerli LU, Schiffer E, Zürbig P, et al. Uninary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics, 2008, 7(2):290-298.
|
| [15] |
Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing pre-eclampsia. Hypertension, 2007, 50(1):137-142.
|
| [16] |
Ramsay JE, Jamieson N, Greer IA, et al. Paradoxical elevation in adiponectin concentrations in women with pre-eclampsia. Hypertension, 2003, 42(5):891-894.
|
| [17] |
Kenny LC, Dun WB, Ellis DI, et al. Novel biomarkers for preeclampsia detected using metabolomics and machine learning. Metabolomics, 2005, 1(3):227-234.
|